Hatzimichael, E., Murray, S., & Briasoulis, E. (2013). Absence of BRAF exon 15 mutations in multiple myeloma and Waldenström’s macroglobulinemia questions its validity as a therapeutic target in plasma cell neoplasias. e-Century Publishing Corporation.
Citação norma ChicagoHatzimichael, Eleftheria, Samuel Murray, and Evangelos Briasoulis. Absence of BRAF Exon 15 Mutations in Multiple Myeloma and Waldenström’s Macroglobulinemia Questions Its Validity As a Therapeutic Target in Plasma Cell Neoplasias. e-Century Publishing Corporation, 2013.
Citação norma MLAHatzimichael, Eleftheria, Samuel Murray, and Evangelos Briasoulis. Absence of BRAF Exon 15 Mutations in Multiple Myeloma and Waldenström’s Macroglobulinemia Questions Its Validity As a Therapeutic Target in Plasma Cell Neoplasias. e-Century Publishing Corporation, 2013.